KRASG12C‐inhibitor‐based combination therapies for pancreatic cancer: insights from drug screening.

Autor: Tapia Contreras, Constanza1 (AUTHOR), Falke, Jonas Dominik1 (AUTHOR), Seifert, Dana‐Magdalena1 (AUTHOR), Schneider, Carolin1 (AUTHOR), Krauß, Lukas1 (AUTHOR), Fang, Xin1 (AUTHOR), Müller, Denise2 (AUTHOR), Demirdizen, Engin1 (AUTHOR), Spitzner, Melanie1 (AUTHOR), De Oliveira, Tiago1 (AUTHOR), Schneeweis, Christian3 (AUTHOR), Gaedcke, Jochen1,4 (AUTHOR), Kaulfuß, Silke4,5 (AUTHOR), Mirzakhani, Kimia4,5 (AUTHOR), Wollnik, Bernd4,5,6 (AUTHOR), Conrads, Karly4,7 (AUTHOR), Beißbarth, Tim4,7,8,9 (AUTHOR), Salinas, Gabriela4,10 (AUTHOR), Hügel, Jonas4,11 (AUTHOR), Beyer, Nils4,11 (AUTHOR)
Zdroj: Molecular Oncology. Sep2024, p1. 16p. 5 Illustrations.
Databáze: Academic Search Ultimate
Externí odkaz: